Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne L Traves

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|March 21, 2007
Viral-associated exacerbations of asthma and COPDSuzanne L Traves, David Proud
Current Molecular Medicine|August 12, 2008
Th17 cells in airway diseasesSuzanne L Traves, Louise E Donnelly
American Journal of Respiratory Cell and Molecular Biology|October 17, 2013
Transcriptional and epigenetic modulation of human rhinovirus-induced CXCL10 production by cigarette smokeMagdalena H Hudy, Suzanne L Traves, David Proud
Journal of Leukocyte Biology|May 25, 2004
Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2Suzanne L Traves, Susan J Smith, Peter J Barnes, et al.
The Journal of Biological Chemistry|November 8, 2015
Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDSSuharsh Shah, Mahmoud M Mostafa, Andrew McWhae, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2016
Chemokine release from human rhinovirus-infected airway epithelial cells promotes fibroblast migrationChristopher Shelfoon, Sami Shariff, Suzanne L Traves, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2007
4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) is a selective, pseudo-irreversible orthosteric antagonist at the prostacyclin (IP)-receptor expressed by human airway epithelial cells: IP-receptor-mediated inhibition of CXCL9 and CXCL10 releaseLinda M Ayer, Sylvia M Wilson, Suzanne L Traves, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 14, 2012
Effect of incremental exercise on airway and systemic inflammation in patients with COPDWarren J Davidson, Wendy S Verity, Suzanne L Traves, et al.
Chest|October 11, 2007
CXCR3 and CCR5 chemokines in induced sputum from patients with COPDClaudia Costa, Rogerio Rufino, Suzanne L Traves, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2009
Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cellsSylvia M Wilson, Pamela Shen, Christopher F Rider, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|March 21, 2007
Viral-associated exacerbations of asthma and COPDSuzanne L Traves, David Proud
Current Molecular Medicine|August 12, 2008
Th17 cells in airway diseasesSuzanne L Traves, Louise E Donnelly
American Journal of Respiratory Cell and Molecular Biology|October 17, 2013
Transcriptional and epigenetic modulation of human rhinovirus-induced CXCL10 production by cigarette smokeMagdalena H Hudy, Suzanne L Traves, David Proud
Journal of Leukocyte Biology|May 25, 2004
Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2Suzanne L Traves, Susan J Smith, Peter J Barnes, et al.
The Journal of Biological Chemistry|November 8, 2015
Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDSSuharsh Shah, Mahmoud M Mostafa, Andrew McWhae, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2016
Chemokine release from human rhinovirus-infected airway epithelial cells promotes fibroblast migrationChristopher Shelfoon, Sami Shariff, Suzanne L Traves, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2007
4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) is a selective, pseudo-irreversible orthosteric antagonist at the prostacyclin (IP)-receptor expressed by human airway epithelial cells: IP-receptor-mediated inhibition of CXCL9 and CXCL10 releaseLinda M Ayer, Sylvia M Wilson, Suzanne L Traves, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 14, 2012
Effect of incremental exercise on airway and systemic inflammation in patients with COPDWarren J Davidson, Wendy S Verity, Suzanne L Traves, et al.
Chest|October 11, 2007
CXCR3 and CCR5 chemokines in induced sputum from patients with COPDClaudia Costa, Rogerio Rufino, Suzanne L Traves, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2009
Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cellsSylvia M Wilson, Pamela Shen, Christopher F Rider, et al.
Pageof 2